Penserra Capital Management LLC Concert Pharmaceuticals, Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$2.69 - $4.22 $1,990 - $3,122	-740 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$3.17 - $4.15 $31 - $41	10 Added 1.37%	740 $2,000
Q1 2021 May 13, 2021	SELL	$4.86 - $13.07 $48 - $130	-10 Reduced 1.35%	730 $3,000
Q4 2020 Feb 12, 2021	BUY	$9.48 - $12.84 $7,015 - $9,501	740 New	740 $9,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.